Current status:
Cancelled Post Market
Current status date:
2014-06-20
DIN:
02321750
Electronic product monograph is not available
Company:
SORRES PHARMA INC
SUITE 100
6111 Royalmount Ave
Montreal
Quebec
Canada
H4P 2T4
Dosage form(s):
Tablet (Chewable)
Route(s) of administration:
Oral
Number of active ingredient(s):
1
American Hospital Formulary Service (AHFS):
See footnote 3
28:08.04.24
Anatomical Therapeutic Chemical (ATC):
See footnote 4
N02BA01 ACETYLSALICYLIC ACID
List of active ingredient(s)
Active ingredient(s)
See footnote8
|
Strength |
ACETYLSALICYLIC ACID
|
80 MG
|